Mitsubishi UFJ Trust & Banking Corp Sells 2,848 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mitsubishi UFJ Trust & Banking Corp lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.4% in the 4th quarter, HoldingsChannel.com reports. The fund owned 204,100 shares of the company’s stock after selling 2,848 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in GE HealthCare Technologies were worth $15,957,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. CoreFirst Bank & Trust bought a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $25,000. Continuum Advisory LLC lifted its stake in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after buying an additional 168 shares during the last quarter. Runnymede Capital Advisors Inc. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth $28,000. Bank of Jackson Hole Trust acquired a new position in GE HealthCare Technologies in the 4th quarter valued at $32,000. Finally, Flagship Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the 4th quarter worth $34,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $80.01 on Friday. The company has a market capitalization of $36.59 billion, a price-to-earnings ratio of 18.48, a PEG ratio of 3.19 and a beta of 1.13. The company has a 50-day moving average of $86.70 and a 200-day moving average of $85.86. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.17%. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of recent analyst reports. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their price target for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Citigroup upped their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.